The Apo gene's genetic variants: hidden role in Asian vascular risk
- 16 April 2024
- journal article
- review article
- Published by Springer Nature in neurogenetics
- Vol. 25 (3) , 157-164
Abstract
Vascular risk factors, including diabetes, hypertension, hyperlipidemia, and obesity, pose significant health threats with implications extending to neuropsychiatric disorders such as stroke and Alzheimer's disease. The Asian population, in particular, appears to be disproportionately affected due to unique genetic predispositions, as well as epigenetic factors such as dietary patterns and lifestyle habits. Existing management strategies often fall short of addressing these specific needs, leading to greater challenges in prevention and treatment. This review highlights a significant gap in our understanding of the impact of genetic screening in the early detection and tailored treatment of vascular risk factors among the Asian population. Apolipoprotein, a key player in cholesterol metabolism, is primarily associated with dyslipidemia, yet emerging evidence suggests its involvement in conditions such as diabetes, hypertension, and obesity. While genetic variants of vascular risk are ethnic-dependent, current evidence indicates that epigenetics also exhibits ethnic specificity. Understanding the interplay between Apolipoprotein and genetics, particularly within diverse ethnic backgrounds, has the potential to refine risk stratification and enhance precision in management. For Caucasian carrying the APOA5 rs662799 C variant, pharmacological interventions are recommended, as dietary interventions may not be sufficient. In contrast, for Asian populations with the same genetic variant, dietary modifications are initially advised. Should dyslipidemia persist, the consideration of pharmaceutical agents such as statins is recommended.Keywords
This publication has 49 references indexed in Scilit:
- RETRACTED: The interplay between monosodium glutamate (MSG) consumption and metabolic disordersHeliyon, 2023
- Adipose cell-free DNA in diabetesClinica Chimica Acta, 2022
- Longitudinal association of Apolipoprotein E polymorphism with lipid profile, type 2 diabetes and metabolic syndrome: Results from a 15 year follow-up studyDiabetes Research and Clinical Practice, 2022
- Dietary Patterns and the Risk of Dyslipidemia in Korean AdultsJournal of the Academy of Nutrition and Dietetics, 2021
- The exchangeable apolipoproteins in lipid metabolism and obesityClinica Chimica Acta, 2020
- Cardiovascular risk factors and Parkinson's disease in 500,000 Chinese adultsAnnals of Clinical and Translational Neurology, 2019
- Implication of the rs670 variant of APOA1 gene with lipid profile, serum adipokine levels and components of metabolic syndrome in adult obese subjectsClinical Nutrition, 2019
- Association between ApoE polymorphism and hypertension: A meta-analysis of 28 studies including 5898 cases and 7518 controlsGene, 2018
- Is the “South Asian Phenotype” Unique to South Asians? Comparing Cardiometabolic Risk Factors in the CARRS and NHANES StudiesGlobal Heart, 2016
- Polymorphisms in apolipoprotein E and apolipoprotein A-V do not influence the lipid response to rosuvastatin but are associated with baseline lipid levels in Chinese patients with hyperlipidemiaJournal of Clinical Lipidology, 2012